Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville Read more
Gilead and insitro Announce Strategic Collaboration to Discover and Develop Novel Therapies for NASH Read more
Invite from Ziva Abraham, Chair at SMi’s 3rd Annual Pharma Microbiology West Coast Conference 2019 Read more
Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene Therapy Read more
Novartis announces FDA filing acceptance and Priority Review of brolucizumab (RTH258) for patients with wet AMD Read more